Hermetica Superfood Encyclopedia
The Short Answer
Dogoyaro contains azadirachtin, nimbolide, gedunin, nimbin, and quercetin as its primary bioactive compounds, which exert antimalarial, antimicrobial, and anti-inflammatory effects through membrane disruption, cytokine suppression, and modulation of PI3K/Akt signaling. In animal chemosuppression studies, leaf extract at 800 mg/kg body weight reduced Plasmodium parasitemia by 75.3%, and leaf extract demonstrated a 28 mm zone of inhibition against Candida albicans in controlled in vitro assays.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keyworddogoyaro benefits
Dogoyaro — botanical close-up
Health Benefits
**Antimalarial Activity**
Azadirachtin, the principal bioactive limonoid, interferes with Plasmodium parasite replication; leaf extract at 800 mg/kg body weight achieved 75.3% parasitemia suppression in rodent malaria models, validating its traditional use in Hausa fever management.
**Antimicrobial and Antifungal Effects**
Nimbin, nimbidin, and quercetin disrupt microbial membrane integrity, causing leakage of intracellular contents; leaf extracts produced a 28 mm inhibition zone against Candida albicans and up to 95% antibacterial activity in hexane fraction assays.
**Anti-inflammatory and Immunomodulation**
Neem extracts significantly reduce proinflammatory cytokine release, including TNF-α and IL-6, while simultaneously elevating CD4+ and CD8+ T-cell counts, supporting immune balance during infection.
**Antioxidant Protection**
Methanolic leaf extracts scavenge nitric oxide (IC50 6.38 mg/ml), DPPH radicals (IC50 6.65 mg/ml), superoxide radicals (IC50 9.21 mg/ml), and hydroxyl radicals (IC50 4.35 mg/ml), reducing oxidative stress implicated in skin aging and systemic disease.
**Skin Infection Management**
Nimbidin and polyphenolic flavonoids such as luteolin and caffeic acid suppress dermatophytes and bacterial skin pathogens; topical application of leaf or bark extracts is a cornerstone of Hausa dermatological practice for ringworm, eczema, and infected wounds.
**Potential Anticancer Properties**
Limonoids nimbolide and gedunin reduce autophagy flux and upregulate PI3K/Akt signal transduction in cancer cell lines, suggesting cytotoxic potential, though evidence remains preclinical and requires human validation.
**Antiparasitic and Insecticidal Properties**
Salannin and azadirachtin disrupt insect and ectoparasite hormonal signaling (ecdysone interference), supporting traditional use of neem leaf decoctions for lice, scabies, and soil-transmitted helminth exposure reduction.
Origin & History
Natural habitat
Azadirachta indica, commonly called neem, is native to the Indian subcontinent but has been naturalized across tropical and subtropical West Africa, including Nigeria, Ghana, and Senegal, where it is widely known by its Hausa name 'Dogoyaro,' meaning 'tall tree.' It thrives in semi-arid environments with well-drained soils, tolerating drought and poor soil conditions, and is commonly cultivated along roadsides, in compounds, and at farm boundaries across the Sahel and Guinea savanna zones. In northern Nigeria particularly, the tree has been deliberately planted for shade, soil stabilization, and medicinal access, with every part of the plant — leaf, bark, seed, root, and oil — harvested for traditional therapeutic use.
“Azadirachta indica has been integrated into Hausa medical tradition in northern Nigeria for centuries, where it is called 'Dogoyaro' and regarded as one of the most versatile medicinal trees in the region, used for malaria, skin diseases, wound care, dental hygiene via chewing sticks, and as a ceremonial fumigant. In Ayurvedic medicine on the Indian subcontinent, neem is referenced in texts dating back over 4,000 years as 'sarva roga nivarini' (the curer of all ailments), documenting its leaf, bark, seed, and root in treatments ranging from fever to skin disorders. Across West Africa, neem leaf bathing was historically prescribed for smallpox, chickenpox, and measles to reduce skin inflammation and secondary infection, a practice that continues in rural communities where access to pharmaceutical dermatological treatments is limited. The tree's remarkable adaptability to semi-arid climates and its freely accessible medicinal parts have made it a cornerstone of community-level primary healthcare across the Sahel, and its introduction to West Africa — believed to have occurred via Indian colonial trade networks in the 19th century — represents one of the most successful ethnobotanical adoptions in African medical history.”Traditional Medicine
Scientific Research
The evidence base for Dogoyaro is predominantly composed of in vitro assays and rodent animal model studies, with no published large-scale randomized controlled trials in human populations identified in the current literature. Antimalarial activity has been quantified in murine Plasmodium berghei models, where leaf extract at 800 mg/kg achieved 75.3% parasitemia suppression versus 98.3% for pyrimethamine, and bark extract achieved 65.6% at equivalent doses, providing meaningful preclinical benchmarks. Antimicrobial studies using hexane and methanolic fractions have demonstrated reproducible in vitro inhibition zones against Candida albicans (28 mm) and varying antibacterial activity (65–95% depending on extract fraction), but methodological standardization across studies is inconsistent, limiting cross-study comparability. Overall, the evidence tier for Dogoyaro is preliminary-to-moderate; the volume of phytochemical characterization studies is substantial, but the absence of Phase II or Phase III human clinical trials means clinical translation cannot be confidently asserted.
Preparation & Dosage
Traditional preparation
**Leaf Decoction (Traditional Hausa Preparation)**
30–60 g) boiled in 500–1000 ml of water for 20–30 minutes; the filtered liquid is consumed orally (1–2 cups daily) for malaria and fever management, or applied topically to infected skin lesions
Fresh or dried leaves (.
**Bark Decoction**
20–40 g) simmered in water and used as an oral antimalarial preparation or wound wash; bark extract at 800 mg/kg demonstrated 65
Dried bark (.6% parasitemia reduction in animal studies.
**Leaf Powder (Crude Oral Supplement)**
400–800 mg/kg equivalent doses
Dried, ground leaf material is encapsulated or mixed with water; no standardized human dose has been established, but animal studies used .
**Topical Leaf Paste**
Fresh leaves are macerated and applied directly to skin infections, ringworm, and eczematous lesions as a poultice, reflecting the primary traditional dermatological use.
**Cold-Pressed Neem Seed Oil**
Applied topically to skin infections and scalp conditions; concentration of azadirachtin and nimbin varies by extraction method and geographic source.
**Standardized Extracts (Research Grade)**
25–200 mg/ml; no standardized commercial supplement formulation with defined azadirachtin percentage has been established for human therapeutic use
Methanolic and hexane fractions have been used in in vitro studies at concentrations of .
**Timing Note**
Traditional oral decoctions are typically consumed morning and evening during febrile illness; no pharmacokinetic data exists to guide optimal dosing timing in humans.
Nutritional Profile
Neem leaves contain meaningful concentrations of proteins (approximately 7–8% dry weight), carbohydrates, crude fiber, and essential minerals including calcium, phosphorus, iron, and magnesium, though they are not consumed as a dietary staple due to their intensely bitter taste. The phytochemical profile is exceptionally rich: over 300 unique compounds have been identified, with leaf extracts yielding more than 45 bioactive constituents including tetranortriterpenoids (azadirachtin, nimbolide, gedunin, nimbin, nimbidin, salannin), polyphenolic flavonoids (quercetin, luteolin), and phenolic acids (caffeic acid, ferulic acid, vanillic acid, p-coumaric acid, hydroxy-tyrosol, tyrosol, vanillin, pinresinol). Beta-sitosterol, a plant sterol with cholesterol-modulating properties, is also present in fresh leaf fractions. Bioavailability of key limonoids such as azadirachtin is poorly characterized in humans; the compounds are highly lipophilic, suggesting fat co-administration may improve absorption, but no formal pharmacokinetic studies in human subjects have been published to date.
How It Works
Mechanism of Action
Azadirachtin, a tetranortriterpenoid limonoid, exerts antimalarial effects by interfering with Plasmodium falciparum protein synthesis and disrupting ecdysteroid and juvenile hormone analogue pathways in parasitic organisms. Nimbin, nimbidin, and salannin integrate into bacterial and fungal lipid bilayers, compromising membrane integrity and increasing ion permeability, which results in leakage of cytoplasmic nucleotides, proteins, and ions and ultimately cell death. Quercetin and hydroxy-tyrosol, acting as polyphenolic antioxidants, neutralize reactive oxygen species via electron donation, while simultaneously inhibiting NF-κB-mediated inflammatory signaling and reducing proinflammatory cytokine transcription. At the oncological level, nimbolide and gedunin modulate the PI3K/Akt/mTOR pathway, inhibiting pro-survival signaling and reducing autophagic flux in cancer cell models, though these mechanisms have not been validated in human clinical trials.
Clinical Evidence
Clinical evidence for Dogoyaro derives almost entirely from preclinical models; no Phase III randomized controlled trials in humans have been published evaluating leaf extract for malaria, skin infections, or any other primary endpoint. The most quantitatively robust data comes from rodent chemosuppression studies showing 75.3% reduction in Plasmodium parasitemia with leaf extract at 800 mg/kg, a clinically meaningful but dose-limited result compared to standard antimalarials. In vitro antimicrobial studies consistently demonstrate broad-spectrum inhibitory activity against bacteria and Candida, with the most active fractions (methanol-miscible hexane extracts) achieving 95% bacterial inhibition, though these outcomes have not been replicated in human infection models. Confidence in translating these preclinical results to clinical recommendations is low-to-moderate, and practitioners should regard Dogoyaro as a traditionally validated adjunct rather than a clinically proven therapeutic.
Safety & Interactions
Dogoyaro is generally regarded as safe at doses used in traditional preparations (leaf decoctions of 30–60 g per day), but high-dose or concentrated extract consumption carries hepatotoxic risk, and neem oil ingested orally — particularly in children — has been associated with serious adverse events including toxic encephalopathy, metabolic acidosis, and death in multiple case reports from India and West Africa. Neem compounds are known to possess antifertility properties demonstrated in animal studies, including spermicidal and embryotoxic effects, making oral use contraindicated during pregnancy and inadvisable for individuals actively attempting conception. Potential drug interactions include additive hypoglycemic effects when combined with insulin or oral antidiabetic medications (neem extracts demonstrate blood glucose-lowering activity in animal models), and theoretical potentiation of immunosuppressive therapy due to T-cell modulating effects. No established maximum safe daily dose has been formally validated in human clinical trials, and consumers should exercise caution with commercially processed neem supplements where azadirachtin concentration is not standardized or declared.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Azadirachta indicaNeemDogoyaroNim treeIndian lilacMargosaDongoyaroKohomba
Frequently Asked Questions
Can dogoyaro (neem leaf) treat malaria?
Dogoyaro leaf extract demonstrated 75.3% suppression of Plasmodium parasitemia in rodent malaria models at a dose of 800 mg/kg body weight, driven primarily by the bioactive compound azadirachtin. However, this compares to 98.3% suppression for the standard drug pyrimethamine, and no controlled human clinical trials have confirmed equivalent efficacy in people. Dogoyaro decoctions remain a widely used first-line traditional remedy in Hausa communities for febrile malaria, but they should not replace confirmed antimalarial medications in clinically diagnosed cases.
How do you prepare dogoyaro leaf for skin infections?
The most common traditional Hausa preparation is a leaf decoction made by boiling 30–60 g of fresh or dried neem leaves in 500–1000 ml of water for 20–30 minutes, straining the liquid, and applying it topically to infected skin areas using a clean cloth. A poultice of freshly macerated leaves can also be applied directly to ringworm, eczema, or wound infections, providing localized delivery of nimbin, nimbidin, and quercetin, which disrupt fungal and bacterial membranes. Neem seed oil pressed from kernels is alternatively applied to skin lesions undiluted or mixed with a carrier oil for fungal and scabies management.
Is dogoyaro (neem) safe to drink as a tea or decoction?
Leaf decoctions at traditional doses (30–60 g of leaves per preparation, consumed 1–2 times daily) are generally considered safe for short-term use in adults, with a long history of use across West Africa and South Asia without widespread reports of serious harm at these concentrations. However, neem oil should never be consumed orally, as case reports have documented toxic encephalopathy, vomiting, metabolic acidosis, and deaths — particularly in children — following ingestion of neem oil. Pregnant women and individuals on antidiabetic or immunosuppressive medications should avoid oral neem preparations due to antifertility effects demonstrated in animals and potential drug interactions.
What are the active compounds in dogoyaro that make it medicinal?
Dogoyaro (Azadirachta indica) contains over 300 phytochemical compounds, with the most pharmacologically active being azadirachtin (antimalarial, antiparasitic), nimbolide and gedunin (anticancer, anti-inflammatory limonoids), nimbin and nimbidin (antimicrobial), salannin (insecticidal), and polyphenolic flavonoids including quercetin and luteolin (antioxidant, antifungal). Phenolic acids such as caffeic acid, ferulic acid, and p-coumaric acid contribute additional antioxidant and anti-inflammatory activity. The concentration of these compounds varies significantly based on geographic growing conditions, season of harvest, and plant part used, meaning potency is not consistent across preparations.
Does dogoyaro interact with any medications?
Neem extracts have demonstrated blood glucose-lowering effects in animal studies, creating a risk of additive hypoglycemia when combined with insulin, metformin, sulfonylureas, or other antidiabetic drugs. The immunomodulatory effects of neem — specifically its ability to elevate CD4+ and CD8+ T-cell counts and reduce proinflammatory cytokines — could theoretically antagonize immunosuppressive drugs such as corticosteroids, cyclosporine, or tacrolimus used in transplant patients or autoimmune conditions. Additionally, the highly lipophilic neem limonoids may interact with CYP450 hepatic metabolism pathways, potentially altering plasma concentrations of co-administered drugs, though this has not been formally studied in humans.
What is the difference between dogoyaro leaf extract and neem oil for treating skin conditions?
Dogoyaro leaf extract is water- or alcohol-soluble and contains nimbin, nimbidin, and quercetin that disrupt microbial membranes, making it effective for bacterial and fungal skin infections when applied topically or ingested. Neem oil, derived from the seed, has a different phytochemical profile with higher concentrations of fatty acids and is typically used as a topical emollient with antimicrobial properties, but may be less potent for systemic infection support. Leaf extracts are generally preferred for internal use to support immunity, while oil is favored for direct skin application due to better adherence and penetration.
Who should avoid dogoyaro supplementation, and are there specific populations at higher risk of adverse effects?
Pregnant and nursing women should avoid dogoyaro due to historical use as an abortifacient and potential effects on lactation; children under 3 years may be too sensitive to its potent alkaloid content. Individuals with autoimmune conditions, those on immunosuppressant medications, or those with severe liver impairment should consult a healthcare provider, as dogoyaro's immune-stimulating properties could complicate these conditions. People with known allergies to Meliaceae family plants (mahogany, chinaberry) may experience cross-reactivity.
What does current clinical evidence show about dogoyaro's antimalarial effectiveness compared to conventional antimalarials?
Preclinical rodent models demonstrate that dogoyaro leaf extract at 800 mg/kg achieves 75.3% parasitemia suppression, supporting its traditional use in Hausa fever management, but clinical trials in human malaria patients remain limited. While azadirachtin's mechanism—interfering with Plasmodium parasite replication—is well-documented in laboratory settings, the evidence base does not yet match the efficacy and safety profile of WHO-approved antimalarials like artemisinin combinations. Dogoyaro is best viewed as a supportive traditional remedy rather than a replacement for evidence-based malaria treatment.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w dogoyaro-azadirachta-indica curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
